Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

Qi Han, Yan Gu, Huimin Xiang, Linyao Zhang, Yan Wang, Chan Yang, Jun Li, Chelsea Steiner, Rosa Lapalombella, Jennifer A. Woyach, Yiping Yang, Sinisa Dovat, Chunhua Song, Zheng Ge

Blood blood.2024024130.

https://doi.org/10.1182/blood.2024024130

Published: 2024

Includes: Supplemental data

Journal Articles

Characteristics and Outcome of Diffuse Large B Cell Lymphoma: A Retrospective Single-Institutional Experience

Xue Wu, Zheng Ge

Blood (2024) 144 (Supplement 1): 6438.

https://doi.org/10.1182/blood-2024-206514

Published: 2024

Journal Articles

Dynamic Changes of Key Gene Mutations in the Disease Course of Patients with Chronic Myelomonocytic Leukemia

Xin Yan, Sr., Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6743.

https://doi.org/10.1182/blood-2024-206853

Published: 2024

Journal Articles

Decitabine Plus All- Trans Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial

Blood (2024) 144 (Supplement 1): 663.

https://doi.org/10.1182/blood-2024-200433

Published: 2024

Journal Articles

Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Blood (2024) 144 (Supplement 1): 304.

https://doi.org/10.1182/blood-2024-206377

Published: 2024

Journal Articles

Dynamic Changes of Genetic Mutations in AML Patients from Diagnosis to Complete Remission and Relapse

Xin Yan, Sr., Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6108.

https://doi.org/10.1182/blood-2024-207314

Published: 2024

Journal Articles

A Study to Assess the Efficacy of Venetoclax Combined with Homoharringtonine and Azacitidine in De Novo Acute Myeloid Leukemia

Yanqing Huang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 6071.

https://doi.org/10.1182/blood-2024-205100

Published: 2024

Journal Articles

Microbiological Analysis of Bloodstream Infections in Patients with Acute Leukemia and the Association with Prognosis

Rui Ge, Yanqing Huang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 5978.

https://doi.org/10.1182/blood-2024-207346

Published: 2024

Journal Articles

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide in B-Cell Acute Lymphoblastic Leukemia By Downregulating TCL1A Expression

Huimin Xiang, Qi Han, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 5764.

https://doi.org/10.1182/blood-2024-202484

Published: 2024

Journal Articles

Newly-Acquired and Clonally-Increased Mutations in TP53 and RAS Pathways Promote Progressive Disease and Leukemic Transformation in Patients with Myelodysplatic Neoplasms

Xin Yan, Sr., Yulu Tian, Yan Gu, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 3224.

https://doi.org/10.1182/blood-2024-206378

Published: 2024

Journal Articles

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Yan Wang, Fei Wang, Haoan Wu, Qi Han, Yu Zhang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 2788.

https://doi.org/10.1182/blood-2024-202461

Published: 2024

Journal Articles

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Blood (2024) 144 (Supplement 1): 2882.

https://doi.org/10.1182/blood-2024-199412

Published: 2024

Journal Articles

Synergistic Effect of EZH2 Inhibitor Dznep and Flavonoid GL-V9 in AML through Inhibition Hells and Induction of DNA Damage

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 4145.

https://doi.org/10.1182/blood-2024-202407

Published: 2024

Journal Articles

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Jun Li, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5686.

https://doi.org/10.1182/blood-2023-185714

Published: 2023

Journal Articles

Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

Liya Ma, Wenli Yang, Xinping Zhou, Li Ye, Gaixiang Xu, Chao Hu, Yingwan Luo, Chunmei Yang, Zheng Ge, Hongyan Tong

Blood (2023) 142 (Supplement 1): 1856.

https://doi.org/10.1182/blood-2023-183101

Published: 2023

Journal Articles

Clinical Application of the IPSS-M Prognostic Score in Myelodysplastic Syndrome

Jian Cheng, Jiangnan Liu, Zheng Ge, Xinyu Zhang, Qiucheng Zhang, Bao-An Chen, Jinlong Ma

Blood (2023) 142 (Supplement 1): 6465.

https://doi.org/10.1182/blood-2023-182524

Published: 2023

Journal Articles

A Novel Natural Derivative GL-V9 Inducing Mitotic Catastrophe and Displaying a Synergistic Anti-Tumor Effect with EZH2 Inhibitor in Acute Myeloid Leukemia

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 7137.

https://doi.org/10.1182/blood-2023-186141

Published: 2023

Journal Articles

HDAC Inhibitor Synergizes with GL-V9, a Derivative of Wogonin, to Suppress Acute Myeloid Leukemia By Downregulating ESPL1 and PLK4

Chan Yang, Qinglong Guo, Hui Hui, Hui Li, Siyu Gu, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2023-185510

Published: 2023

Journal Articles

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide on Cell Proliferation Arrest and Apoptosis in Acute Myeloid Leukemia

Huimin Xiang, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 6000.

https://doi.org/10.1182/blood-2023-185928

Published: 2023

Journal Articles

Casein Kinase II Inhibitor Sensitizes the Anti-Tumor Effect of EZH2 Inhibitor By Suppressing FOSL1 Expression in Acute Myeloid Leukemia

Chan Yang, Chunhua Song, Zheng Ge

Blood (2023) 142 (Supplement 1): 5996.

https://doi.org/10.1182/blood-2023-185378

Published: 2023

NARROW

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

Characteristics and Outcome of Diffuse Large B Cell Lymphoma: A Retrospective Single-Institutional Experience

Dynamic Changes of Key Gene Mutations in the Disease Course of Patients with Chronic Myelomonocytic Leukemia

Decitabine Plus All- Trans Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial

Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Dynamic Changes of Genetic Mutations in AML Patients from Diagnosis to Complete Remission and Relapse

A Study to Assess the Efficacy of Venetoclax Combined with Homoharringtonine and Azacitidine in De Novo Acute Myeloid Leukemia

Microbiological Analysis of Bloodstream Infections in Patients with Acute Leukemia and the Association with Prognosis

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide in B-Cell Acute Lymphoblastic Leukemia By Downregulating TCL1A Expression

Newly-Acquired and Clonally-Increased Mutations in TP53 and RAS Pathways Promote Progressive Disease and Leukemic Transformation in Patients with Myelodysplatic Neoplasms

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Synergistic Effect of EZH2 Inhibitor Dznep and Flavonoid GL-V9 in AML through Inhibition Hells and Induction of DNA Damage

Azacitidine Combined with Novel Flavonoid Derivative GL-V9 Demonstrated Synergistic Anti-Leukemia Effect in Acute Myeloid Leukemia By Targeting DDIT4/mTOR Signaling

Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

Clinical Application of the IPSS-M Prognostic Score in Myelodysplastic Syndrome

A Novel Natural Derivative GL-V9 Inducing Mitotic Catastrophe and Displaying a Synergistic Anti-Tumor Effect with EZH2 Inhibitor in Acute Myeloid Leukemia

HDAC Inhibitor Synergizes with GL-V9, a Derivative of Wogonin, to Suppress Acute Myeloid Leukemia By Downregulating ESPL1 and PLK4

Synergistic Effect of CK2 Inhibitor CX-4945 with HDACi Chidamide on Cell Proliferation Arrest and Apoptosis in Acute Myeloid Leukemia

Casein Kinase II Inhibitor Sensitizes the Anti-Tumor Effect of EZH2 Inhibitor By Suppressing FOSL1 Expression in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only